Prapassorn Poolchanuan

Prapassorn Poolchanuan

Researcher

Mahidol University, Thailand

Email: prapassorn.pol@mahidol.ac.th

 

 

 

 

VALIDATE Role: Network Associate

Research Keywords

Sepsis, COVID-19, biomarkers

Biography

Dr. Prapassorn Poolchanuan graduated from the Biotechnology program at Chulalongkorn University. She obtained a postdoctoral fellowship at Mahidol University, where she conducted research on the immune response to COVID-19 in the Department of Microbiology and Immunology at the Faculty of Tropical Medicine. Currently, she is a researcher in the same department and is actively involved in researching biomarkers in sepsis patients for early diagnosis and improving patients' outcomes. Furthermore, she is leading the SEACOVARIANTS project, which aims to investigate the influence of SARS- CoV-2 variants on antibody and T-cell responses in Southeast Asia population.

 

Related websites

 

Key Publications

  1. Poolchanuan P, Matsee W, Sengyee S, Siripoon T, Dulsuk A, Phunpang R, Pisutsan P, Piyaphanee W, Luvira V, and Chantratita N. Dynamics of different classes and subclasses of antibody responses to severe acute respiratory syndrome Coronavirus 2 variants after Coronavirus Disease vaccination in Thailand. mSphere. 2023;8(1):e0046522. (Impact factor: 5.029, Q1)
  2. Poolchanuan P, Coston T, Hantrakun V, Chamnan P, Wongsuvan G, Chantratita N, Limmathurotsakul D, West E, and Wright S. Biological endotypes differentiate mortality risk in patients hospitalized with suspected infection in southeast Asia.(manuscript in submission)
  3. Khongsiri W, Rotejanaprasert C, Poolchanuan P, Chantratita N, Leaungwutiwong P, Luvira V, and Kosoltanapiwat N. A clinical, virological, and antibody response study of SARS-CoV-2 infection in Thai patients. (manuscript in preparation)
  4. Poolchanuan P, Tiacharoen T, Dulsuk A, Phunpang R, Sengyee S, Runcharoen C, Hemtong O, Chowplijit S, Chuapaknam V, Kosoltanapiwat N, Khongsiri W, SiripoonT, Piyaphanee W, Tan LV, Dunachie S, Tan CW, Chantratita W, Luvira V, and Chantratita N. Longitudinal analysis of antibody responses to SARS-CoV-2 variants in breakthrough and unvaccinated COVID-19 patients (manuscript in preparation)